Effects of excitotoxic lesions of the central or basolateral nucleus of the amygdala on naloxone-precipitated withdrawal-induced conditioned place aversion in morphine-dependent rats

Brain Research

Volumn 958, Issue 2, 2002, Pages 423-428

  Watanabe, Takeshi ^a   Yamamoto, Rie ^a   Maeda, Akifumi ^a   Nakagawa, Takayuki ^a   Minami, Masabumi ^a   Satoh, Masamichi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Basolateral nucleus of the amygdala; Central nucleus of the amygdala; Conditioned place aversion; Drugs of abuse: opioids and others; Excitotoxic lesion; Morphine withdrawal; Neural basis of behavior

Indexed keywords

MORPHINE; NALOXONE;

AMYGDALOID NUCLEUS; ARTICLE; AVERSION; BASOLATERAL MEMBRANE; CELL DAMAGE; CYTOTOXICITY; DRUG EFFECT; DRUG WITHDRAWAL; MORPHINE ADDICTION; NONHUMAN; PRIORITY JOURNAL;

AMYGDALA; ANIMALS; CONDITIONING (PSYCHOLOGY); EXCITATORY AMINO ACID AGONISTS; MALE; MORPHINE DEPENDENCE; NALOXONE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0037184693     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03468-6     Document Type: Article

References (30)

1. Calvino B., Lagowska J., Ben-Ari Y. Morphine withdrawal syndrome: differential participation of structures located within the amygdaloid complex and striatum of the rat. Brain Res. 177:1979;19-34.
2. Delfs J.M., Zhu Y., Druhan J.P., Aston-Jones G. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature. 403:2000;430-434.
3. Everitt B.J., Parkinson J.A., Olmstead M.C., Arroyo M., Robeldo P., Robbins T.W. Associative processes in addiction and reward - the role of amygdala-ventral striatal subsystems. Ann. NY Acad. Sci. 877:1999;412-438.
4. Gallagher M., Chiba A.A. The amygdala and emotion. Curr. Opin. Neurobiol. 6:1996;221-227.
5. Gewirtz J.C., Davis M. Second-order fear conditioning prevented by blocking NMDA receptors in amygdala. Nature. 388:1997;471-474.
6. Gibson R.D., Tingstad J.E. Formulation of a morphine implantation pellet suitable for tolerance-physical dependence studies in mice. J. Pharm. Sci. 59:1970;426-427.
7. Gracy K.N., Dankiewicz L.A., Koob G.F. Opiate withdrawal-induced Fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion. Neuropsychopharmacology. 24:2001;152-160.
8. Guen S.L., Gestreau C., Besson J.M. Sensitivity to naloxone of the behavioral signs of morphine withdrawal and c-Fos expression in the rat CNS: a quantitative dose-response analysis. J. Comp. Neurol. 433:2001;272-297.
9. Hand T.H., Koob G.F., Stinus L., LeMoal M. Aversive properties of opiate receptor blockade: evidence for exclusively central mediation in naive and morphine-dependent rats. Brain Res. 474:1988;364-368.
10. Hatfield T., Han J.S., Conley M., Gallagher M., Holland P. Neurotoxic lesions of basolateral, but not central, amygdala interfere with Pavlovian second-order conditioning and reinforcer devaluation effects. J. Neurosci. 16:1996;5256-5265.
11. Higgins G.A., Sellers E.M. Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs. Pharmacol. Biochem. Behav. 48:1994;1-8.
12. Hitchcott P.K., Phillips G.D. Double dissociation of the behavioural effects of R(+) 7-OH-DPAT infusions in the central and basolateral amygdala nuclei upon Pavlovian and instrumental conditioned appetitive behaviours. Psychpharmacolgy. 140:1998;458-469.
13. Kelsey J.E., Arnold S.R. Lesion of the dorsomedial amygdala, but not the nucleus accumbens, reduce the aversiveness of morphine withdrawal in rats. Behav. Neurosci. 108:1994;1119-1127.
14. Killcross S., Robbins T.W., Everitt B.J. Different types of fear-conditioned behaviour mediated by separate nuclei within amygdala. Nature. 388:1997;377-380.
15. Koob G.F. The role of the striatopallidal and extended amygdala systems in drug addiction. Ann. NY Acad. Sci. 877:1999;445-460.
16. Koob G.F., Wall T.L., Bloom F.E. Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal. Psychopharmacology. 98:1989;530-534.
17. Kruzich P.J., See R.E. Differential contributions of the basolateral and central amygdala in the acquisition and expression of conditioned relapse to cocaine-seeking behavior. J. Neurosci. 21:(RC155):2001;1-5.
18. LeDoux J.E., Cicchetti P., Xagoraris A., Romanski L.M. The lateral amygdaloid nucleus - sensory interface of the amygdala in fear conditioning. J. Neurosci. 10:1990;1062-1069.
19. Maldonado R., Stinus L., Gold L.H., Koob G.F. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261:1992;669-677.
20. Mucha R.F. Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat. Brain Res. 418:1987;214-220.
21. Parkinson J.A., Everitt B.J. Dissociable roles of the central and basolateral amygdala in appetitive emotional learning. Eur. J. Neurosci. 12:2000;405-413.
22. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1998;Academic Press, San Diego, CA.
23. Schaefer G.J., Michael R.P. Changes in response rates and reinforcement thresholds for intracranial self-stimulation during morphine withdrawal. Pharmacol. Biochem. Behav. 25:1986;1263-1269.
24. Schulteis G., Ahmed S.H., Morse A.C., Koob G.F., Everitt B.J. Conditioning and opiate withdrawal: the amygdala links neutral stimuli with the agony of overcoming drug addiction. Nature. 405:2000;1013-1014.
25. Schulteis G., Markou A., Gold L.H., Stinus L., Koob G.F. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J. Pharmcol. Exp. Ther. 271:1994;1391-1398.
26. Stinus L., LeMoal M., Koob G.F. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience. 37:1990;767-773.
27. Stornetta R.L., Norton F.E., Guyenet P.G. Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats. Brain Res. 624:1993;19-28.
28. Tremblay E.C., Charton G. Anatomical correlates of morphine-withdrawal syndrome: differential participation of structures located within the limbic system and striatum. Neurosci. Lett. 23:1981;137-142.
29. Watanabe T., Nakagawa T., Yamamoto R., Maeda A., Minami M., Satoh M. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Jpn. J. Pharmacol. 88:2002;399-406.
30. Wooten G.F., DiSefano P., Collins R.C. Regional cerebral glucose utilization during morphine withdrawal in the rat. Proc. Natl. Acad. Sci. USA. 79:1982;3360-3364.